Suppr超能文献

68Ga 标记的甘露糖化人血清白蛋白(MSA)作为正电子发射断层扫描用淋巴结成像剂的研制。

Development of 68Ga-labeled mannosylated human serum albumin (MSA) as a lymph node imaging agent for positron emission tomography.

机构信息

Department of Nuclear Medicine, Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, South Korea.

出版信息

Nucl Med Biol. 2011 Apr;38(3):371-9. doi: 10.1016/j.nucmedbio.2010.09.010. Epub 2010 Dec 3.

Abstract

INTRODUCTION

Although many sentinel lymph node (SLN) imaging agents labeled with (99m)Tc have been developed, no positron-emitting agent has been specifically designed for SLN imaging. Furthermore, the development of the beta probe and the requirement for better image resolution have increased the need for a positron-emitting SLN imaging agent. Here, we describe the development of a novel positron-emitting SLN imaging agent labeled with (68)Ga.

METHODS

A mannosylated human serum albumin (MSA) was synthesized by conjugating α-d-mannopyranosylphenyl isothiocyanate to human serum albumin in sodium carbonate buffer (pH 9.5), and then 2-(p-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid was conjugated to synthesize NOTA-MSA. Numbers of mannose and NOTA units conjugated in NOTA-MSA were determined by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. NOTA-MSA was labeled with (68)Ga at room temperature. The stability of (68)Ga-NOTA-MSA was checked in labeling medium at room temperature and in human serum at 37°C. Biodistribution in normal ICR mice was investigated after tail vein injection, and micro-positron emission tomography (PET) images were obtained after injecting (68)Ga-NOTA-MSA into a tail vein or a footpad.

RESULTS

The numbers of conjugated α-d-mannopyranosylphenyl isothiocyanate and 2-(p-isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid units in NOTA-MSA were 10.6 and 6.6, respectively. The labeling efficiency of (68)Ga-NOTA-MSA was greater than 99% at room temperature, and its stability was greater than 99% at 4 h. Biodistribution and micro-PET studies of (68)Ga-NOTA-MSA showed high liver and spleen uptakes after intravenous injection. (68)Ga-NOTA-MSA injected into a footpad rapidly migrated to the lymph node.

CONCLUSIONS

(68)Ga-NOTA-MSA was successfully developed as a novel SLN imaging agent for PET. NOTA-MSA is easily labeled at high efficiency, and subcutaneously administered (68)Ga-NOTA-MSA was found to migrate rapidly to the lymph node.

摘要

简介

虽然已经开发出许多用 (99m)Tc 标记的前哨淋巴结 (SLN) 成像剂,但尚未专门设计用于 SLN 成像的正电子发射剂。此外,β探针的发展和对更好的图像分辨率的要求增加了对正电子发射 SLN 成像剂的需求。在这里,我们描述了一种新型的用 (68)Ga 标记的正电子发射 SLN 成像剂的开发。

方法

通过在碳酸钠缓冲液 (pH 9.5) 中将α-d-甘露吡喃基苯基异硫氰酸酯与人血清白蛋白偶联,合成甘露糖基化人血清白蛋白 (MSA),然后将 2-(对异硫氰酸苄基)-1,4,7-三氮杂环壬烷-1,4,7-三乙酸偶联以合成 NOTA-MSA。通过基质辅助激光解吸电离飞行时间质谱法测定 NOTA-MSA 中结合的甘露糖和 NOTA 单元的数量。室温下用 (68)Ga 标记 NOTA-MSA。在室温下的标记介质中和 37°C 下的人血清中检查 (68)Ga-NOTA-MSA 的稳定性。尾静脉注射后研究正常 ICR 小鼠的生物分布,并将 (68)Ga-NOTA-MSA 注入尾静脉或足底后获得微正电子发射断层扫描 (PET) 图像。

结果

NOTA-MSA 中结合的α-d-甘露吡喃基苯基异硫氰酸酯和 2-(对异硫氰酸苄基)-1,4,7-三氮杂环壬烷-1,4,7-三乙酸单元的数量分别为 10.6 和 6.6。室温下 (68)Ga-NOTA-MSA 的标记效率大于 99%,4 小时时其稳定性大于 99%。(68)Ga-NOTA-MSA 的生物分布和微 PET 研究表明,静脉注射后肝脏和脾脏摄取量高。注入足底的 (68)Ga-NOTA-MSA 迅速迁移到淋巴结。

结论

成功开发了 (68)Ga-NOTA-MSA 作为用于 PET 的新型 SLN 成像剂。NOTA-MSA 易于高效标记,并且皮下给予的 (68)Ga-NOTA-MSA 迅速迁移到淋巴结。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验